These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 35003086

  • 1. Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status.
    Gong S, Jin S, Li Y, Jiang W, Zhang Z, Shen Z, Wang J, Zhou H, Liu X, Xu X, Ding X, Shi Y, Liu H.
    Front Immunol; 2021; 12():769802. PubMed ID: 35003086
    [Abstract] [Full Text] [Related]

  • 2. Urinary Soluble CD163 in Active Renal Vasculitis.
    O'Reilly VP, Wong L, Kennedy C, Elliot LA, O'Meachair S, Coughlan AM, O'Brien EC, Ryan MM, Sandoval D, Connolly E, Dekkema GJ, Lau J, Abdulahad WH, Sanders JS, Heeringa P, Buckley C, O'Brien C, Finn S, Cohen CD, Lindemeyer MT, Hickey FB, O'Hara PV, Feighery C, Moran SM, Mellotte G, Clarkson MR, Dorman AJ, Murray PT, Little MA.
    J Am Soc Nephrol; 2016 Sep; 27(9):2906-16. PubMed ID: 26940094
    [Abstract] [Full Text] [Related]

  • 3. Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis.
    Endo N, Tsuboi N, Furuhashi K, Shi Y, Du Q, Abe T, Hori M, Imaizumi T, Kim H, Katsuno T, Ozaki T, Kosugi T, Matsuo S, Maruyama S.
    Nephrol Dial Transplant; 2016 Dec; 31(12):2023-2033. PubMed ID: 27242373
    [Abstract] [Full Text] [Related]

  • 4. Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA Nephropathy.
    Li J, Lv J, Wong MG, Shi S, Zan J, Monaghan H, Perkovic V, Zhang H, TESTING Study Biomarker Group.
    Kidney Int Rep; 2024 Oct; 9(10):3016-3026. PubMed ID: 39430181
    [Abstract] [Full Text] [Related]

  • 5. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF.
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [Abstract] [Full Text] [Related]

  • 6. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
    Zhang T, Li H, Vanarsa K, Gidley G, Mok CC, Petri M, Saxena R, Mohan C.
    Front Immunol; 2020 Mar; 11():671. PubMed ID: 32351512
    [Abstract] [Full Text] [Related]

  • 7. Urinary soluble CD163 is a putative non-invasive biomarker for primary sclerosing cholangitis.
    Elger T, Fererberger T, Huss M, Sommersberger S, Mester P, Stoeckert P, Gunawan S, Liebisch G, Loibl J, Kandulski A, Müller M, Buechler C, Tews HC.
    Exp Mol Pathol; 2024 Jun; 137():104900. PubMed ID: 38729058
    [Abstract] [Full Text] [Related]

  • 8. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
    Kazankov K, Barrera F, Møller HJ, Bibby BM, Vilstrup H, George J, Grønbaek H.
    Hepatology; 2014 Aug; 60(2):521-30. PubMed ID: 24623375
    [Abstract] [Full Text] [Related]

  • 9. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL, Zhang YL, Shu XM, Yang HB, Zhang L, Chen F, Lu X, Wang GC.
    J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
    [Abstract] [Full Text] [Related]

  • 10. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y, Suzuki Y, Hozumi H, Mori K, Kono M, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suzuki D, Ogawa N, Nakashima R, Mimori T, Iwashita T, Suda T.
    Arthritis Res Ther; 2017 Jan 19; 19(1):9. PubMed ID: 28103926
    [Abstract] [Full Text] [Related]

  • 11. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
    Laursen TL, Wong GL, Kazankov K, Sandahl T, Møller HJ, Hamilton-Dutoit S, George J, Chan HL, Grønbaek H.
    J Gastroenterol Hepatol; 2018 Feb 19; 33(2):484-491. PubMed ID: 28618015
    [Abstract] [Full Text] [Related]

  • 12. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.
    Eur J Haematol; 2014 Jul 19; 93(1):41-7. PubMed ID: 24612259
    [Abstract] [Full Text] [Related]

  • 13. Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis.
    Aendekerk JP, Timmermans SAMEG, Busch MH, Potjewijd J, Heeringa P, Damoiseaux JGMC, Reutelingsperger CP, van Paassen P, Limburg Renal Registry.
    Clin J Am Soc Nephrol; 2020 Dec 07; 15(12):1740-1748. PubMed ID: 33203735
    [Abstract] [Full Text] [Related]

  • 14. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
    Baeten D, Møller HJ, Delanghe J, Veys EM, Moestrup SK, De Keyser F.
    Arthritis Rheum; 2004 May 07; 50(5):1611-23. PubMed ID: 15146432
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study.
    Su L, Feng L, Liu C, Jiang Z, Li M, Xiao K, Yan P, Jia Y, Feng D, Xie L.
    BMC Nephrol; 2012 Sep 26; 13():123. PubMed ID: 23013330
    [Abstract] [Full Text] [Related]

  • 16. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
    Kazankov K, Tordjman J, Møller HJ, Vilstrup H, Poitou C, Bedossa P, Bouillot JL, Clement K, Grønbaek H.
    J Gastroenterol Hepatol; 2015 Aug 26; 30(8):1293-300. PubMed ID: 25772748
    [Abstract] [Full Text] [Related]

  • 17. Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study.
    Dekkema GJ, Abdulahad WH, Bijma T, Moran SM, Ryan L, Little MA, Stegeman CA, Heeringa P, Sanders JF.
    Nephrol Dial Transplant; 2019 Feb 01; 34(2):234-242. PubMed ID: 29506265
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients.
    Tanimura H, Mizuno K, Okamoto H.
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul 22; 32(2):99-105. PubMed ID: 26278688
    [Abstract] [Full Text] [Related]

  • 19. Elevated Numbers of Circulating Very Small Embryonic-Like Stem Cells (VSELs) and Intermediate CD14++CD16+ Monocytes in IgA Nephropathy.
    Eljaszewicz A, Kleina K, Grubczak K, Radzikowska U, Zembko P, Kaczmarczyk P, Tynecka M, Dworzanczyk K, Naumnik B, Moniuszko M.
    Stem Cell Rev Rep; 2018 Oct 22; 14(5):686-693. PubMed ID: 30022351
    [Abstract] [Full Text] [Related]

  • 20. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.
    Mejia-Vilet JM, Zhang XL, Cruz C, Cano-Verduzco ML, Shapiro JP, Nagaraja HN, Morales-Buenrostro LE, Rovin BH.
    J Am Soc Nephrol; 2020 Jun 22; 31(6):1335-1347. PubMed ID: 32300067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.